nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—hematologic cancer	0.359	1	CpDpCtD
Almotriptan—FMO3—Dasatinib—hematologic cancer	0.0678	0.157	CbGbCtD
Almotriptan—CYP1A2—Anagrelide—hematologic cancer	0.0203	0.0471	CbGbCtD
Almotriptan—CYP2E1—Thalidomide—hematologic cancer	0.013	0.0301	CbGbCtD
Almotriptan—CYP2E1—Dacarbazine—hematologic cancer	0.0112	0.0259	CbGbCtD
Almotriptan—CYP2C8—Bortezomib—hematologic cancer	0.0111	0.0258	CbGbCtD
Almotriptan—CYP2D6—Lomustine—hematologic cancer	0.0108	0.025	CbGbCtD
Almotriptan—CYP1A2—Carmustine—hematologic cancer	0.0107	0.0247	CbGbCtD
Almotriptan—CYP2D6—Idarubicin—hematologic cancer	0.0096	0.0223	CbGbCtD
Almotriptan—CYP2C19—Bortezomib—hematologic cancer	0.00934	0.0217	CbGbCtD
Almotriptan—CYP1A2—Methoxsalen—hematologic cancer	0.00906	0.021	CbGbCtD
Almotriptan—CYP2E1—Mitoxantrone—hematologic cancer	0.00867	0.0201	CbGbCtD
Almotriptan—CYP1A2—Bortezomib—hematologic cancer	0.00862	0.02	CbGbCtD
Almotriptan—CYP2C8—Ifosfamide—hematologic cancer	0.00854	0.0198	CbGbCtD
Almotriptan—CYP1A2—Daunorubicin—hematologic cancer	0.00825	0.0191	CbGbCtD
Almotriptan—CYP2D6—Hydroxyurea—hematologic cancer	0.00817	0.0189	CbGbCtD
Almotriptan—CYP2C19—Thalidomide—hematologic cancer	0.00814	0.0189	CbGbCtD
Almotriptan—CYP1A2—Alitretinoin—hematologic cancer	0.00808	0.0187	CbGbCtD
Almotriptan—CYP2C19—Teniposide—hematologic cancer	0.00777	0.018	CbGbCtD
Almotriptan—CYP1A2—Thalidomide—hematologic cancer	0.00751	0.0174	CbGbCtD
Almotriptan—CYP2C8—Nilotinib—hematologic cancer	0.00742	0.0172	CbGbCtD
Almotriptan—CYP3A4—Bexarotene—hematologic cancer	0.00737	0.0171	CbGbCtD
Almotriptan—CYP2C19—Ifosfamide—hematologic cancer	0.00717	0.0166	CbGbCtD
Almotriptan—CYP2D6—Bortezomib—hematologic cancer	0.0071	0.0165	CbGbCtD
Almotriptan—CYP3A4—Lomustine—hematologic cancer	0.00685	0.0159	CbGbCtD
Almotriptan—CYP3A4—Busulfan—hematologic cancer	0.00685	0.0159	CbGbCtD
Almotriptan—CYP2C19—Imatinib—hematologic cancer	0.00685	0.0159	CbGbCtD
Almotriptan—CYP1A2—Dacarbazine—hematologic cancer	0.00646	0.015	CbGbCtD
Almotriptan—CYP1A2—Imatinib—hematologic cancer	0.00632	0.0146	CbGbCtD
Almotriptan—CYP3A4—Thiotepa—hematologic cancer	0.00611	0.0142	CbGbCtD
Almotriptan—CYP2E1—Etoposide—hematologic cancer	0.00546	0.0127	CbGbCtD
Almotriptan—CYP2D6—Imatinib—hematologic cancer	0.0052	0.0121	CbGbCtD
Almotriptan—CYP1A2—Dasatinib—hematologic cancer	0.00507	0.0118	CbGbCtD
Almotriptan—CYP3A4—Methoxsalen—hematologic cancer	0.00475	0.011	CbGbCtD
Almotriptan—CYP2D6—Nilotinib—hematologic cancer	0.00473	0.011	CbGbCtD
Almotriptan—CYP2D6—Vinorelbine—hematologic cancer	0.00469	0.0109	CbGbCtD
Almotriptan—CYP3A4—Bortezomib—hematologic cancer	0.00452	0.0105	CbGbCtD
Almotriptan—CYP2C19—Prednisone—hematologic cancer	0.00451	0.0105	CbGbCtD
Almotriptan—CYP2E1—Dexamethasone—hematologic cancer	0.00449	0.0104	CbGbCtD
Almotriptan—CYP3A4—Daunorubicin—hematologic cancer	0.00432	0.01	CbGbCtD
Almotriptan—CYP2C8—Etoposide—hematologic cancer	0.00408	0.00947	CbGbCtD
Almotriptan—CYP3A4—Cytarabine—hematologic cancer	0.00381	0.00884	CbGbCtD
Almotriptan—CYP3A4—Teniposide—hematologic cancer	0.00375	0.00871	CbGbCtD
Almotriptan—CYP3A4—Ifosfamide—hematologic cancer	0.00346	0.00803	CbGbCtD
Almotriptan—CYP2C8—Dexamethasone—hematologic cancer	0.00336	0.00778	CbGbCtD
Almotriptan—CYP3A4—Imatinib—hematologic cancer	0.00331	0.00767	CbGbCtD
Almotriptan—CYP1A2—Etoposide—hematologic cancer	0.00316	0.00733	CbGbCtD
Almotriptan—CYP3A4—Ruxolitinib—hematologic cancer	0.00312	0.00723	CbGbCtD
Almotriptan—CYP3A4—Nilotinib—hematologic cancer	0.00301	0.00697	CbGbCtD
Almotriptan—CYP3A4—Vinorelbine—hematologic cancer	0.00298	0.00692	CbGbCtD
Almotriptan—CYP2D6—Vinblastine—hematologic cancer	0.00289	0.0067	CbGbCtD
Almotriptan—CYP2C19—Dexamethasone—hematologic cancer	0.00282	0.00653	CbGbCtD
Almotriptan—CYP3A4—Triamcinolone—hematologic cancer	0.00273	0.00633	CbGbCtD
Almotriptan—CYP3A4—Dasatinib—hematologic cancer	0.00266	0.00616	CbGbCtD
Almotriptan—CYP3A4—Mitoxantrone—hematologic cancer	0.00263	0.00609	CbGbCtD
Almotriptan—CYP3A4—Betamethasone—hematologic cancer	0.00234	0.00543	CbGbCtD
Almotriptan—CYP3A4—Prednisolone—hematologic cancer	0.00231	0.00535	CbGbCtD
Almotriptan—CYP3A4—Prednisone—hematologic cancer	0.00218	0.00506	CbGbCtD
Almotriptan—CYP2D6—Dexamethasone—hematologic cancer	0.00214	0.00496	CbGbCtD
Almotriptan—CYP3A4—Irinotecan—hematologic cancer	0.00207	0.00479	CbGbCtD
Almotriptan—CYP3A4—Vinblastine—hematologic cancer	0.00184	0.00426	CbGbCtD
Almotriptan—CYP3A4—Vincristine—hematologic cancer	0.00181	0.00419	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—hematologic cancer	0.00178	0.00412	CbGbCtD
Almotriptan—CYP3A4—Etoposide—hematologic cancer	0.00166	0.00384	CbGbCtD
Almotriptan—Melatonin—CALR—hematologic cancer	0.00141	0.582	CrCbGaD
Almotriptan—CYP3A4—Dexamethasone—hematologic cancer	0.00136	0.00316	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—hematologic cancer	0.00113	0.00262	CbGbCtD
Almotriptan—Sumatriptan—ABCG2—hematologic cancer	0.000302	0.125	CrCbGaD
Almotriptan—Melatonin—MPO—hematologic cancer	0.000277	0.114	CrCbGaD
Almotriptan—FMO3—lung—hematologic cancer	0.000256	0.0805	CbGeAlD
Almotriptan—FMO3—testis—hematologic cancer	0.000241	0.076	CbGeAlD
Almotriptan—Melatonin—ESR1—hematologic cancer	0.000208	0.0857	CrCbGaD
Almotriptan—CYP2C19—hematopoietic system—hematologic cancer	0.000195	0.0613	CbGeAlD
Almotriptan—MAOA—hematopoietic system—hematologic cancer	0.000191	0.06	CbGeAlD
Almotriptan—FMO3—lymph node—hematologic cancer	0.000175	0.0551	CbGeAlD
Almotriptan—CYP2C8—hematopoietic system—hematologic cancer	0.00017	0.0535	CbGeAlD
Almotriptan—CYP1A2—hematopoietic system—hematologic cancer	0.000159	0.0501	CbGeAlD
Almotriptan—CYP2E1—hematopoietic system—hematologic cancer	0.000143	0.045	CbGeAlD
Almotriptan—CYP2C19—blood—hematologic cancer	0.000129	0.0406	CbGeAlD
Almotriptan—MAOA—blood—hematologic cancer	0.000126	0.0397	CbGeAlD
Almotriptan—Sumatriptan—ABCB1—hematologic cancer	0.000126	0.0519	CrCbGaD
Almotriptan—CYP3A4—hematopoietic system—hematologic cancer	0.000115	0.0362	CbGeAlD
Almotriptan—CYP2D6—hematopoietic system—hematologic cancer	0.000113	0.0357	CbGeAlD
Almotriptan—CYP2C8—blood—hematologic cancer	0.000113	0.0354	CbGeAlD
Almotriptan—MAOA—lung—hematologic cancer	0.000111	0.0348	CbGeAlD
Almotriptan—CYP1A2—blood—hematologic cancer	0.000105	0.0332	CbGeAlD
Almotriptan—MAOA—testis—hematologic cancer	0.000104	0.0329	CbGeAlD
Almotriptan—Eletriptan—ABCB1—hematologic cancer	0.000102	0.042	CrCbGaD
Almotriptan—CYP2E1—blood—hematologic cancer	9.48e-05	0.0298	CbGeAlD
Almotriptan—CYP2C8—testis—hematologic cancer	9.31e-05	0.0293	CbGeAlD
Almotriptan—CYP1A2—lung—hematologic cancer	9.24e-05	0.0291	CbGeAlD
Almotriptan—CYP2E1—lung—hematologic cancer	8.31e-05	0.0262	CbGeAlD
Almotriptan—CYP2E1—testis—hematologic cancer	7.84e-05	0.0247	CbGeAlD
Almotriptan—CYP3A4—blood—hematologic cancer	7.63e-05	0.024	CbGeAlD
Almotriptan—MAOA—lymph node—hematologic cancer	7.57e-05	0.0238	CbGeAlD
Almotriptan—CYP2D6—blood—hematologic cancer	7.5e-05	0.0236	CbGeAlD
Almotriptan—CYP2D6—testis—hematologic cancer	6.21e-05	0.0195	CbGeAlD
Almotriptan—Nausea—Vincristine—hematologic cancer	2.58e-05	0.000157	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—hematologic cancer	2.57e-05	0.000156	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—hematologic cancer	2.57e-05	0.000156	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisolone—hematologic cancer	2.55e-05	0.000155	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—hematologic cancer	2.55e-05	0.000155	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—hematologic cancer	2.55e-05	0.000155	CcSEcCtD
Almotriptan—Dyspepsia—Betamethasone—hematologic cancer	2.55e-05	0.000155	CcSEcCtD
Almotriptan—Dyspepsia—Dexamethasone—hematologic cancer	2.55e-05	0.000155	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—hematologic cancer	2.53e-05	0.000154	CcSEcCtD
Almotriptan—Asthenia—Etoposide—hematologic cancer	2.52e-05	0.000153	CcSEcCtD
Almotriptan—Body temperature increased—Triamcinolone—hematologic cancer	2.52e-05	0.000153	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—hematologic cancer	2.52e-05	0.000153	CcSEcCtD
Almotriptan—Nausea—Mitoxantrone—hematologic cancer	2.51e-05	0.000153	CcSEcCtD
Almotriptan—Nausea—Irinotecan—hematologic cancer	2.51e-05	0.000153	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—hematologic cancer	2.5e-05	0.000152	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.5e-05	0.000152	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.5e-05	0.000152	CcSEcCtD
Almotriptan—Back pain—Methotrexate—hematologic cancer	2.49e-05	0.000152	CcSEcCtD
Almotriptan—Fatigue—Betamethasone—hematologic cancer	2.49e-05	0.000152	CcSEcCtD
Almotriptan—Fatigue—Dexamethasone—hematologic cancer	2.49e-05	0.000152	CcSEcCtD
Almotriptan—Chills—Epirubicin—hematologic cancer	2.49e-05	0.000151	CcSEcCtD
Almotriptan—Pruritus—Etoposide—hematologic cancer	2.49e-05	0.000151	CcSEcCtD
Almotriptan—Shock—Prednisone—hematologic cancer	2.48e-05	0.000151	CcSEcCtD
Almotriptan—Pain—Betamethasone—hematologic cancer	2.47e-05	0.00015	CcSEcCtD
Almotriptan—Pain—Dexamethasone—hematologic cancer	2.47e-05	0.00015	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—hematologic cancer	2.47e-05	0.00015	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—hematologic cancer	2.47e-05	0.00015	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—hematologic cancer	2.46e-05	0.000149	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—hematologic cancer	2.45e-05	0.000149	CcSEcCtD
Almotriptan—Nausea—Gemcitabine—hematologic cancer	2.44e-05	0.000149	CcSEcCtD
Almotriptan—Vomiting—Cisplatin—hematologic cancer	2.44e-05	0.000148	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—hematologic cancer	2.44e-05	0.000148	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—hematologic cancer	2.43e-05	0.000148	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—hematologic cancer	2.43e-05	0.000148	CcSEcCtD
Almotriptan—Rash—Cisplatin—hematologic cancer	2.42e-05	0.000147	CcSEcCtD
Almotriptan—Dermatitis—Cisplatin—hematologic cancer	2.42e-05	0.000147	CcSEcCtD
Almotriptan—Erythema—Epirubicin—hematologic cancer	2.41e-05	0.000147	CcSEcCtD
Almotriptan—Diarrhoea—Etoposide—hematologic cancer	2.4e-05	0.000146	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—hematologic cancer	2.4e-05	0.000146	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—hematologic cancer	2.39e-05	0.000145	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—hematologic cancer	2.39e-05	0.000145	CcSEcCtD
Almotriptan—Feeling abnormal—Dexamethasone—hematologic cancer	2.38e-05	0.000145	CcSEcCtD
Almotriptan—Feeling abnormal—Betamethasone—hematologic cancer	2.38e-05	0.000145	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—hematologic cancer	2.38e-05	0.000145	CcSEcCtD
Almotriptan—Tension—Epirubicin—hematologic cancer	2.37e-05	0.000144	CcSEcCtD
Almotriptan—Gastrointestinal pain—Betamethasone—hematologic cancer	2.37e-05	0.000144	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.37e-05	0.000144	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—hematologic cancer	2.36e-05	0.000144	CcSEcCtD
Almotriptan—Hypersensitivity—Triamcinolone—hematologic cancer	2.35e-05	0.000143	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—hematologic cancer	2.34e-05	0.000143	CcSEcCtD
Almotriptan—Back pain—Epirubicin—hematologic cancer	2.33e-05	0.000142	CcSEcCtD
Almotriptan—Malaise—Methotrexate—hematologic cancer	2.33e-05	0.000141	CcSEcCtD
Almotriptan—Dizziness—Etoposide—hematologic cancer	2.32e-05	0.000141	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—hematologic cancer	2.32e-05	0.000141	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—hematologic cancer	2.32e-05	0.000141	CcSEcCtD
Almotriptan—Chills—Doxorubicin—hematologic cancer	2.3e-05	0.00014	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.29e-05	0.00014	CcSEcCtD
Almotriptan—Dizziness—Prednisolone—hematologic cancer	2.29e-05	0.000139	CcSEcCtD
Almotriptan—Asthenia—Triamcinolone—hematologic cancer	2.29e-05	0.000139	CcSEcCtD
Almotriptan—Body temperature increased—Betamethasone—hematologic cancer	2.29e-05	0.000139	CcSEcCtD
Almotriptan—Abdominal pain—Dexamethasone—hematologic cancer	2.29e-05	0.000139	CcSEcCtD
Almotriptan—Body temperature increased—Dexamethasone—hematologic cancer	2.29e-05	0.000139	CcSEcCtD
Almotriptan—Abdominal pain—Betamethasone—hematologic cancer	2.29e-05	0.000139	CcSEcCtD
Almotriptan—Nausea—Cisplatin—hematologic cancer	2.28e-05	0.000139	CcSEcCtD
Almotriptan—Insomnia—Prednisone—hematologic cancer	2.28e-05	0.000138	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—hematologic cancer	2.27e-05	0.000138	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—hematologic cancer	2.26e-05	0.000137	CcSEcCtD
Almotriptan—Pruritus—Triamcinolone—hematologic cancer	2.26e-05	0.000137	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—hematologic cancer	2.25e-05	0.000137	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—hematologic cancer	2.24e-05	0.000136	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—hematologic cancer	2.23e-05	0.000136	CcSEcCtD
Almotriptan—Vomiting—Etoposide—hematologic cancer	2.23e-05	0.000136	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—hematologic cancer	2.23e-05	0.000136	CcSEcCtD
Almotriptan—Agitation—Epirubicin—hematologic cancer	2.22e-05	0.000135	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—hematologic cancer	2.22e-05	0.000135	CcSEcCtD
Almotriptan—Rash—Etoposide—hematologic cancer	2.22e-05	0.000135	CcSEcCtD
Almotriptan—Dermatitis—Etoposide—hematologic cancer	2.21e-05	0.000135	CcSEcCtD
Almotriptan—Headache—Etoposide—hematologic cancer	2.2e-05	0.000134	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—hematologic cancer	2.2e-05	0.000133	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—hematologic cancer	2.2e-05	0.000133	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—hematologic cancer	2.2e-05	0.000133	CcSEcCtD
Almotriptan—Tension—Doxorubicin—hematologic cancer	2.19e-05	0.000133	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—hematologic cancer	2.19e-05	0.000133	CcSEcCtD
Almotriptan—Rash—Prednisolone—hematologic cancer	2.19e-05	0.000133	CcSEcCtD
Almotriptan—Dermatitis—Prednisolone—hematologic cancer	2.18e-05	0.000133	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.18e-05	0.000133	CcSEcCtD
Almotriptan—Malaise—Epirubicin—hematologic cancer	2.18e-05	0.000132	CcSEcCtD
Almotriptan—Fatigue—Prednisone—hematologic cancer	2.17e-05	0.000132	CcSEcCtD
Almotriptan—Headache—Prednisolone—hematologic cancer	2.17e-05	0.000132	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—hematologic cancer	2.17e-05	0.000132	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—hematologic cancer	2.17e-05	0.000132	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—hematologic cancer	2.17e-05	0.000132	CcSEcCtD
Almotriptan—Syncope—Epirubicin—hematologic cancer	2.16e-05	0.000132	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—hematologic cancer	2.16e-05	0.000131	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—hematologic cancer	2.13e-05	0.00013	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—hematologic cancer	2.12e-05	0.000129	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—hematologic cancer	2.12e-05	0.000129	CcSEcCtD
Almotriptan—Dizziness—Triamcinolone—hematologic cancer	2.11e-05	0.000128	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—hematologic cancer	2.11e-05	0.000128	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—hematologic cancer	2.1e-05	0.000128	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Almotriptan—Nausea—Etoposide—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—hematologic cancer	2.08e-05	0.000127	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—hematologic cancer	2.08e-05	0.000126	CcSEcCtD
Almotriptan—Asthenia—Dexamethasone—hematologic cancer	2.08e-05	0.000126	CcSEcCtD
Almotriptan—Asthenia—Betamethasone—hematologic cancer	2.08e-05	0.000126	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—hematologic cancer	2.07e-05	0.000126	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Almotriptan—Nausea—Prednisolone—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—hematologic cancer	2.05e-05	0.000125	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—hematologic cancer	2.05e-05	0.000124	CcSEcCtD
Almotriptan—Pruritus—Betamethasone—hematologic cancer	2.05e-05	0.000124	CcSEcCtD
Almotriptan—Pruritus—Dexamethasone—hematologic cancer	2.05e-05	0.000124	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—hematologic cancer	2.04e-05	0.000124	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.04e-05	0.000124	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—hematologic cancer	2.04e-05	0.000124	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—hematologic cancer	2.03e-05	0.000123	CcSEcCtD
Almotriptan—Vomiting—Triamcinolone—hematologic cancer	2.03e-05	0.000123	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—hematologic cancer	2.01e-05	0.000122	CcSEcCtD
Almotriptan—Rash—Triamcinolone—hematologic cancer	2.01e-05	0.000122	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—hematologic cancer	2.01e-05	0.000122	CcSEcCtD
Almotriptan—Dermatitis—Triamcinolone—hematologic cancer	2.01e-05	0.000122	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—hematologic cancer	2.01e-05	0.000122	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—hematologic cancer	2e-05	0.000122	CcSEcCtD
Almotriptan—Headache—Triamcinolone—hematologic cancer	2e-05	0.000121	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Almotriptan—Diarrhoea—Betamethasone—hematologic cancer	1.98e-05	0.00012	CcSEcCtD
Almotriptan—Diarrhoea—Dexamethasone—hematologic cancer	1.98e-05	0.00012	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—hematologic cancer	1.97e-05	0.00012	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—hematologic cancer	1.97e-05	0.00012	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—hematologic cancer	1.96e-05	0.000119	CcSEcCtD
Almotriptan—Shock—Epirubicin—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—hematologic cancer	1.93e-05	0.000117	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—hematologic cancer	1.93e-05	0.000117	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—hematologic cancer	1.92e-05	0.000117	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.92e-05	0.000117	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—hematologic cancer	1.91e-05	0.000116	CcSEcCtD
Almotriptan—Dizziness—Dexamethasone—hematologic cancer	1.91e-05	0.000116	CcSEcCtD
Almotriptan—Dizziness—Betamethasone—hematologic cancer	1.91e-05	0.000116	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—hematologic cancer	1.89e-05	0.000115	CcSEcCtD
Almotriptan—Nausea—Triamcinolone—hematologic cancer	1.89e-05	0.000115	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—hematologic cancer	1.89e-05	0.000115	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.89e-05	0.000115	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—hematologic cancer	1.88e-05	0.000114	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—hematologic cancer	1.88e-05	0.000114	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—hematologic cancer	1.87e-05	0.000114	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—hematologic cancer	1.86e-05	0.000113	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—hematologic cancer	1.86e-05	0.000113	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—hematologic cancer	1.85e-05	0.000113	CcSEcCtD
Almotriptan—Vomiting—Betamethasone—hematologic cancer	1.84e-05	0.000112	CcSEcCtD
Almotriptan—Vomiting—Dexamethasone—hematologic cancer	1.84e-05	0.000112	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—hematologic cancer	1.84e-05	0.000112	CcSEcCtD
Almotriptan—Rash—Betamethasone—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Almotriptan—Rash—Dexamethasone—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Almotriptan—Dermatitis—Dexamethasone—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Almotriptan—Dermatitis—Betamethasone—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.82e-05	0.00011	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Almotriptan—Headache—Dexamethasone—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Almotriptan—Headache—Betamethasone—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Almotriptan—Asthenia—Prednisone—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Almotriptan—Pain—Methotrexate—hematologic cancer	1.8e-05	0.000109	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.79e-05	0.000109	CcSEcCtD
Almotriptan—Shock—Doxorubicin—hematologic cancer	1.79e-05	0.000109	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—hematologic cancer	1.79e-05	0.000109	CcSEcCtD
Almotriptan—Pruritus—Prednisone—hematologic cancer	1.78e-05	0.000108	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—hematologic cancer	1.78e-05	0.000108	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—hematologic cancer	1.78e-05	0.000108	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—hematologic cancer	1.77e-05	0.000108	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—hematologic cancer	1.77e-05	0.000108	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—hematologic cancer	1.76e-05	0.000107	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—hematologic cancer	1.76e-05	0.000107	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—hematologic cancer	1.75e-05	0.000106	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—hematologic cancer	1.72e-05	0.000105	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—hematologic cancer	1.72e-05	0.000105	CcSEcCtD
Almotriptan—Nausea—Betamethasone—hematologic cancer	1.72e-05	0.000104	CcSEcCtD
Almotriptan—Nausea—Dexamethasone—hematologic cancer	1.72e-05	0.000104	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.7e-05	0.000103	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—hematologic cancer	1.7e-05	0.000103	CcSEcCtD
Almotriptan—Pain—Epirubicin—hematologic cancer	1.68e-05	0.000102	CcSEcCtD
Almotriptan—Dizziness—Prednisone—hematologic cancer	1.67e-05	0.000101	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—hematologic cancer	1.66e-05	0.000101	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—hematologic cancer	1.66e-05	0.000101	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.66e-05	0.000101	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—hematologic cancer	1.65e-05	0.0001	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—hematologic cancer	1.64e-05	9.95e-05	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—hematologic cancer	1.63e-05	9.88e-05	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—hematologic cancer	1.62e-05	9.87e-05	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—hematologic cancer	1.62e-05	9.85e-05	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—hematologic cancer	1.61e-05	9.79e-05	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—hematologic cancer	1.6e-05	9.75e-05	CcSEcCtD
Almotriptan—Vomiting—Prednisone—hematologic cancer	1.6e-05	9.74e-05	CcSEcCtD
Almotriptan—Rash—Prednisone—hematologic cancer	1.59e-05	9.65e-05	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—hematologic cancer	1.59e-05	9.65e-05	CcSEcCtD
Almotriptan—Headache—Prednisone—hematologic cancer	1.58e-05	9.59e-05	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.57e-05	9.57e-05	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—hematologic cancer	1.57e-05	9.55e-05	CcSEcCtD
Almotriptan—Pain—Doxorubicin—hematologic cancer	1.56e-05	9.48e-05	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—hematologic cancer	1.56e-05	9.47e-05	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—hematologic cancer	1.56e-05	9.47e-05	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—hematologic cancer	1.55e-05	9.43e-05	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—hematologic cancer	1.51e-05	9.18e-05	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—hematologic cancer	1.5e-05	9.13e-05	CcSEcCtD
Almotriptan—Nausea—Prednisone—hematologic cancer	1.5e-05	9.1e-05	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.49e-05	9.06e-05	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—hematologic cancer	1.49e-05	9.05e-05	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—hematologic cancer	1.45e-05	8.82e-05	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—hematologic cancer	1.44e-05	8.76e-05	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—hematologic cancer	1.44e-05	8.76e-05	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—hematologic cancer	1.44e-05	8.76e-05	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—hematologic cancer	1.41e-05	8.59e-05	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—hematologic cancer	1.39e-05	8.47e-05	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—hematologic cancer	1.39e-05	8.46e-05	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—hematologic cancer	1.35e-05	8.19e-05	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—hematologic cancer	1.34e-05	8.16e-05	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—hematologic cancer	1.34e-05	8.14e-05	CcSEcCtD
Almotriptan—Rash—Methotrexate—hematologic cancer	1.33e-05	8.07e-05	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—hematologic cancer	1.33e-05	8.06e-05	CcSEcCtD
Almotriptan—Headache—Methotrexate—hematologic cancer	1.32e-05	8.02e-05	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—hematologic cancer	1.31e-05	7.95e-05	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—hematologic cancer	1.3e-05	7.92e-05	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—hematologic cancer	1.29e-05	7.84e-05	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—hematologic cancer	1.25e-05	7.61e-05	CcSEcCtD
Almotriptan—Nausea—Methotrexate—hematologic cancer	1.25e-05	7.6e-05	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—hematologic cancer	1.25e-05	7.58e-05	CcSEcCtD
Almotriptan—Rash—Epirubicin—hematologic cancer	1.24e-05	7.55e-05	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—hematologic cancer	1.24e-05	7.54e-05	CcSEcCtD
Almotriptan—Headache—Epirubicin—hematologic cancer	1.23e-05	7.5e-05	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—hematologic cancer	1.21e-05	7.33e-05	CcSEcCtD
Almotriptan—Nausea—Epirubicin—hematologic cancer	1.17e-05	7.11e-05	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—hematologic cancer	1.16e-05	7.05e-05	CcSEcCtD
Almotriptan—Rash—Doxorubicin—hematologic cancer	1.15e-05	6.99e-05	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—hematologic cancer	1.15e-05	6.98e-05	CcSEcCtD
Almotriptan—Headache—Doxorubicin—hematologic cancer	1.14e-05	6.94e-05	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—hematologic cancer	1.08e-05	6.58e-05	CcSEcCtD
Almotriptan—CYP2E1—Metabolism—GSTP1—hematologic cancer	3.75e-06	9.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.74e-06	9.41e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—BRAF—hematologic cancer	3.74e-06	9.4e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK3—hematologic cancer	3.73e-06	9.38e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CREB1—hematologic cancer	3.71e-06	9.32e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL2—hematologic cancer	3.71e-06	9.32e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6R—hematologic cancer	3.69e-06	9.29e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CREBBP—hematologic cancer	3.69e-06	9.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.68e-06	9.26e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYCS—hematologic cancer	3.68e-06	9.26e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CD—hematologic cancer	3.67e-06	9.23e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—BRAF—hematologic cancer	3.66e-06	9.21e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.66e-06	9.2e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL2—hematologic cancer	3.63e-06	9.12e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NUP98—hematologic cancer	3.62e-06	9.11e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—hematologic cancer	3.62e-06	9.11e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6R—hematologic cancer	3.62e-06	9.1e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CREBBP—hematologic cancer	3.61e-06	9.08e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.58e-06	9.01e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.55e-06	8.94e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAP2K1—hematologic cancer	3.52e-06	8.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.52e-06	8.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.52e-06	8.85e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CD—hematologic cancer	3.5e-06	8.79e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NUP214—hematologic cancer	3.49e-06	8.79e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ACP5—hematologic cancer	3.49e-06	8.76e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA9—hematologic cancer	3.49e-06	8.76e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NQO1—hematologic cancer	3.47e-06	8.73e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CD44—hematologic cancer	3.47e-06	8.73e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3R1—hematologic cancer	3.47e-06	8.72e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—hematologic cancer	3.46e-06	8.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.46e-06	8.69e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.45e-06	8.67e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.45e-06	8.67e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAP2K1—hematologic cancer	3.45e-06	8.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.44e-06	8.65e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CD—hematologic cancer	3.42e-06	8.61e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—hematologic cancer	3.42e-06	8.61e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTR—hematologic cancer	3.42e-06	8.61e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.42e-06	8.61e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.4e-06	8.55e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	3.39e-06	8.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO2—hematologic cancer	3.36e-06	8.44e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—hematologic cancer	3.35e-06	8.43e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGF2—hematologic cancer	3.35e-06	8.42e-05	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—hematologic cancer	3.33e-06	8.38e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3R1—hematologic cancer	3.3e-06	8.3e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.29e-06	8.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYCS—hematologic cancer	3.29e-06	8.26e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGF2—hematologic cancer	3.28e-06	8.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—IDH1—hematologic cancer	3.28e-06	8.24e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.26e-06	8.21e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.26e-06	8.19e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.24e-06	8.16e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.24e-06	8.15e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TXN—hematologic cancer	3.24e-06	8.15e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.24e-06	8.15e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3R1—hematologic cancer	3.23e-06	8.13e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JAK2—hematologic cancer	3.21e-06	8.07e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.21e-06	8.06e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CB—hematologic cancer	3.2e-06	8.04e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CD44—hematologic cancer	3.19e-06	8.03e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NQO1—hematologic cancer	3.19e-06	8.03e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SDC1—hematologic cancer	3.18e-06	8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.17e-06	7.97e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—hematologic cancer	3.15e-06	7.91e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JAK2—hematologic cancer	3.14e-06	7.9e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.14e-06	7.89e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MDM2—hematologic cancer	3.13e-06	7.88e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—hematologic cancer	3.08e-06	7.75e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.07e-06	7.72e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MDM2—hematologic cancer	3.07e-06	7.71e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.05e-06	7.67e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CB—hematologic cancer	3.05e-06	7.67e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MTOR—hematologic cancer	3.05e-06	7.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.05e-06	7.66e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.04e-06	7.64e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYCS—hematologic cancer	3.02e-06	7.6e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3e-06	7.55e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3e-06	7.55e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MTOR—hematologic cancer	2.98e-06	7.51e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CB—hematologic cancer	2.98e-06	7.51e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.98e-06	7.5e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.98e-06	7.5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.94e-06	7.39e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—hematologic cancer	2.91e-06	7.32e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.9e-06	7.28e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.89e-06	7.26e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.87e-06	7.22e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—hematologic cancer	2.86e-06	7.19e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—hematologic cancer	2.85e-06	7.17e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—hematologic cancer	2.83e-06	7.12e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—hematologic cancer	2.8e-06	7.05e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.8e-06	7.05e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—hematologic cancer	2.8e-06	7.04e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—hematologic cancer	2.8e-06	7.04e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NUP98—hematologic cancer	2.8e-06	7.03e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—hematologic cancer	2.79e-06	7.01e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—hematologic cancer	2.77e-06	6.97e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—hematologic cancer	2.76e-06	6.95e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—hematologic cancer	2.75e-06	6.9e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.74e-06	6.89e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—hematologic cancer	2.74e-06	6.89e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—hematologic cancer	2.73e-06	6.86e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—hematologic cancer	2.73e-06	6.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JUN—hematologic cancer	2.72e-06	6.85e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.72e-06	6.83e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.72e-06	6.83e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NQO1—hematologic cancer	2.71e-06	6.8e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CD44—hematologic cancer	2.71e-06	6.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NUP214—hematologic cancer	2.7e-06	6.78e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—hematologic cancer	2.67e-06	6.72e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUN—hematologic cancer	2.67e-06	6.71e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.66e-06	6.7e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.66e-06	6.69e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.66e-06	6.69e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.65e-06	6.66e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTR—hematologic cancer	2.64e-06	6.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.64e-06	6.64e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—hematologic cancer	2.64e-06	6.64e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—EP300—hematologic cancer	2.64e-06	6.63e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.63e-06	6.63e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—hematologic cancer	2.63e-06	6.62e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO2—hematologic cancer	2.59e-06	6.51e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—hematologic cancer	2.59e-06	6.5e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—hematologic cancer	2.58e-06	6.49e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—hematologic cancer	2.58e-06	6.48e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—hematologic cancer	2.57e-06	6.46e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.56e-06	6.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYCS—hematologic cancer	2.56e-06	6.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.54e-06	6.4e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—hematologic cancer	2.52e-06	6.35e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.52e-06	6.34e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—hematologic cancer	2.52e-06	6.33e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.51e-06	6.32e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EP300—hematologic cancer	2.51e-06	6.32e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EP300—hematologic cancer	2.46e-06	6.19e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SDC1—hematologic cancer	2.46e-06	6.18e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.45e-06	6.16e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.45e-06	6.16e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SRC—hematologic cancer	2.44e-06	6.14e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SRC—hematologic cancer	2.39e-06	6.02e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—hematologic cancer	2.38e-06	5.98e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.37e-06	5.97e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—hematologic cancer	2.36e-06	5.92e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.35e-06	5.91e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NRAS—hematologic cancer	2.35e-06	5.91e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—hematologic cancer	2.33e-06	5.86e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.32e-06	5.84e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—hematologic cancer	2.31e-06	5.8e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NRAS—hematologic cancer	2.3e-06	5.79e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.29e-06	5.76e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.26e-06	5.67e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.25e-06	5.66e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—hematologic cancer	2.25e-06	5.66e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—hematologic cancer	2.22e-06	5.59e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.21e-06	5.57e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—hematologic cancer	2.2e-06	5.54e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—hematologic cancer	2.19e-06	5.5e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—hematologic cancer	2.18e-06	5.49e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.18e-06	5.49e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.16e-06	5.44e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—hematologic cancer	2.14e-06	5.39e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—hematologic cancer	2.14e-06	5.38e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.14e-06	5.37e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.13e-06	5.35e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CD44—hematologic cancer	2.09e-06	5.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NQO1—hematologic cancer	2.09e-06	5.25e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.07e-06	5.21e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.07e-06	5.21e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.07e-06	5.21e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.05e-06	5.16e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—hematologic cancer	2.02e-06	5.09e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—hematologic cancer	1.98e-06	4.98e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.98e-06	4.97e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYCS—hematologic cancer	1.98e-06	4.97e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.96e-06	4.94e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.96e-06	4.94e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—hematologic cancer	1.95e-06	4.9e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.95e-06	4.89e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—hematologic cancer	1.92e-06	4.83e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—hematologic cancer	1.86e-06	4.67e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.84e-06	4.62e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.83e-06	4.61e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.83e-06	4.61e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	1.82e-06	4.58e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.82e-06	4.57e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—hematologic cancer	1.8e-06	4.52e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—hematologic cancer	1.76e-06	4.43e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.74e-06	4.38e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.74e-06	4.37e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—hematologic cancer	1.72e-06	4.32e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—hematologic cancer	1.71e-06	4.31e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.7e-06	4.27e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—hematologic cancer	1.7e-06	4.26e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.69e-06	4.24e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—hematologic cancer	1.68e-06	4.23e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.65e-06	4.15e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—hematologic cancer	1.65e-06	4.14e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.64e-06	4.13e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—EP300—hematologic cancer	1.62e-06	4.07e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.61e-06	4.06e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—hematologic cancer	1.61e-06	4.05e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.6e-06	4.02e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.6e-06	4.02e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.6e-06	4.02e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—hematologic cancer	1.59e-06	4.01e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—hematologic cancer	1.58e-06	3.97e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.54e-06	3.87e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—hematologic cancer	1.52e-06	3.82e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.51e-06	3.81e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.51e-06	3.79e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—hematologic cancer	1.49e-06	3.74e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—hematologic cancer	1.47e-06	3.69e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.43e-06	3.59e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.41e-06	3.56e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—EP300—hematologic cancer	1.4e-06	3.52e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.39e-06	3.5e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.35e-06	3.4e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—hematologic cancer	1.34e-06	3.36e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—hematologic cancer	1.31e-06	3.29e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.28e-06	3.21e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—EP300—hematologic cancer	1.25e-06	3.14e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—hematologic cancer	1.2e-06	3.03e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.2e-06	3.01e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.19e-06	2.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.18e-06	2.97e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—EP300—hematologic cancer	1.15e-06	2.89e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.1e-06	2.77e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.04e-06	2.63e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.03e-06	2.6e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—hematologic cancer	1.03e-06	2.59e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—hematologic cancer	1.02e-06	2.56e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.86e-07	2.48e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—hematologic cancer	9.77e-07	2.46e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—EP300—hematologic cancer	9.72e-07	2.45e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.23e-07	2.32e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.11e-07	2.29e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.49e-07	2.14e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—hematologic cancer	8.45e-07	2.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—hematologic cancer	7.87e-07	1.98e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—hematologic cancer	7.54e-07	1.9e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—EP300—hematologic cancer	7.5e-07	1.89e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.19e-07	1.81e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—hematologic cancer	6.94e-07	1.74e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—hematologic cancer	5.88e-07	1.48e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.55e-07	1.4e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—hematologic cancer	4.53e-07	1.14e-05	CbGpPWpGaD
